Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neal Navani

Showing results (71-80 of 127) with videos related to

Pageof 13
Sort By:
Cancer Management and Research|July 24, 2024
UK Stakeholder Perspectives on Surrogate Endpoints in Cancer, and the Potential for UK Real-World Datasets to Validate Their Use in Decision-MakingDavid Baldwin, Jonathan Carmichael, Gordon Cook, et al.
Histopathology|May 20, 2016
PD-L1 testing for lung cancer in the UK: recognizing the challenges for implementationIan A Cree, Richard Booton, Paul Cane, et al.
American Journal of Respiratory and Critical Care Medicine|June 2, 2012
Endobronchial ultrasound-guided transbronchial needle aspiration prevents mediastinoscopies in the diagnosis of isolated mediastinal lymphadenopathy: a prospective trialNeal Navani, David R Lawrence, Shyam Kolvekar, et al.
Chest|August 14, 2015
Transcriptional Profiling of Endobronchial Ultrasound-Guided Lymph Node Samples Aids Diagnosis of Mediastinal LymphadenopathyGillian S Tomlinson, Niclas Thomas, Benjamin M Chain, et al.
Thorax|August 14, 2018
Association between age, deprivation and specific comorbid conditions and the receipt of major surgery in patients with non-small cell lung cancer in England: A population-based studyAurélien Belot, Helen Fowler, Edmund Njeru Njagi, et al.
Thorax|February 13, 2025
Improving uptake of lung cancer screening: an observational study on the impact of timed appointments and remindersAmyn Bhamani, Sindhu Bhaarrati Naidu, Tanya Patrick, et al.
The Lancet. Respiratory Medicine|February 10, 2015
Lung cancer diagnosis and staging with endobronchial ultrasound-guided transbronchial needle aspiration compared with conventional approaches: an open-label, pragmatic, randomised controlled trialNeal Navani, Matthew Nankivell, David R Lawrence, et al.
Thorax|August 18, 2021
Association between time-to-treatment and outcomes in non-small cell lung cancer: a systematic reviewHelen Hall, Adam Tocock, Sarah Burdett, et al.
Journal of Medical Imaging and Radiation Oncology|May 16, 2020
Predictors of patient preference for either whole body magnetic resonance imaging (WB-MRI) or CT/ PET-CT for staging colorectal or lung cancerAnne Miles, Ruth Ec Evans, Steve Halligan, et al.
BMJ Open Respiratory Research|July 16, 2021
Impact on quality of life from multimodality treatment for lung cancer: a randomised controlled feasibility trial of surgery versus no surgery as part of multimodality treatment in potentially resectable stage III-N2 NSCLC (the PIONEER trial)Sally Taylor, Janelle Yorke, Selina Tsim, et al.
Pageof 13

Showing results (71-80 of 127) with videos related to

Sort By:
Pageof 13
Cancer Management and Research|July 24, 2024
UK Stakeholder Perspectives on Surrogate Endpoints in Cancer, and the Potential for UK Real-World Datasets to Validate Their Use in Decision-MakingDavid Baldwin, Jonathan Carmichael, Gordon Cook, et al.
Histopathology|May 20, 2016
PD-L1 testing for lung cancer in the UK: recognizing the challenges for implementationIan A Cree, Richard Booton, Paul Cane, et al.
American Journal of Respiratory and Critical Care Medicine|June 2, 2012
Endobronchial ultrasound-guided transbronchial needle aspiration prevents mediastinoscopies in the diagnosis of isolated mediastinal lymphadenopathy: a prospective trialNeal Navani, David R Lawrence, Shyam Kolvekar, et al.
Chest|August 14, 2015
Transcriptional Profiling of Endobronchial Ultrasound-Guided Lymph Node Samples Aids Diagnosis of Mediastinal LymphadenopathyGillian S Tomlinson, Niclas Thomas, Benjamin M Chain, et al.
Thorax|August 14, 2018
Association between age, deprivation and specific comorbid conditions and the receipt of major surgery in patients with non-small cell lung cancer in England: A population-based studyAurélien Belot, Helen Fowler, Edmund Njeru Njagi, et al.
Thorax|February 13, 2025
Improving uptake of lung cancer screening: an observational study on the impact of timed appointments and remindersAmyn Bhamani, Sindhu Bhaarrati Naidu, Tanya Patrick, et al.
The Lancet. Respiratory Medicine|February 10, 2015
Lung cancer diagnosis and staging with endobronchial ultrasound-guided transbronchial needle aspiration compared with conventional approaches: an open-label, pragmatic, randomised controlled trialNeal Navani, Matthew Nankivell, David R Lawrence, et al.
Thorax|August 18, 2021
Association between time-to-treatment and outcomes in non-small cell lung cancer: a systematic reviewHelen Hall, Adam Tocock, Sarah Burdett, et al.
Journal of Medical Imaging and Radiation Oncology|May 16, 2020
Predictors of patient preference for either whole body magnetic resonance imaging (WB-MRI) or CT/ PET-CT for staging colorectal or lung cancerAnne Miles, Ruth Ec Evans, Steve Halligan, et al.
BMJ Open Respiratory Research|July 16, 2021
Impact on quality of life from multimodality treatment for lung cancer: a randomised controlled feasibility trial of surgery versus no surgery as part of multimodality treatment in potentially resectable stage III-N2 NSCLC (the PIONEER trial)Sally Taylor, Janelle Yorke, Selina Tsim, et al.
Pageof 13